Results 1 to 10 of about 321,381 (359)

HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe [PDF]

open access: yesHIV Medicine, 2021
AbstractObjectivesAlthough direct‐acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV‐coinfected individuals, high rates of reinfection may hamper efforts to eliminate HCV in this population. We investigated reinfection after sustained virological response (SVR) in HIV/HCV‐coinfected individuals in Europe.MethodsFactors associated with odds of
Amele S.   +199 more
openaire   +9 more sources

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community

open access: yesJournal of the Formosan Medical Association, 2021
The HCV core antigen (HCV Ag) assay displays high sensitivity and strong correlation with HCV RNA. However, the feasibility of anti-HCV reflex HCV Ag screening in a community-wide setting is rarely discussed.We performed a two-phase community-based hepatitis C screen in an HCV-prone area of central Taiwan.
Nien-Tzu Hsu   +2 more
exaly   +5 more sources

Epidemiology and natural history of HCV infection

open access: yesNature Reviews Gastroenterology and Hepatology, 2013
Worldwide, an estimated 130–170 million people have HCV infection. HCV prevalence is highest in Egypt at >10% of the general population and China has the most people with HCV (29.8 million).
Jason Grebely   +2 more
exaly   +2 more sources

Interference between miR-21/PTEN/E-Cadherin and Epithelial-Mesenchymal Transition in Various Stages of Chronic HCV Infection [PDF]

open access: yesJournal of Bioscience and Applied Research, 2022
Hepatocellular carcinoma (HCC) is a major complication associated with hepatitis C viral infection (HCV). The epithelial-mesenchymal transition (EMT) is critical in HCC invasion and metastasis.
Yasser Ali   +5 more
doaj   +1 more source

Screening for HCV [PDF]

open access: yesCanadian Medical Association Journal, 2014
We applaud Shah and colleagues[1][1] for raising the issue of establishing a Canadian screening program for hepatitis C. We agree that hepatitis C shows the hallmarks of an infectious disease suited to a screening program,[2][2] but we are concerned that the extrapolation of American data into ...
Fiona G, Kouyoumdjian   +3 more
openaire   +5 more sources

Comparative study on anti-HCV testing using plasma, dried plasma spots (DPS), and dried blood spots (DBS)Highlights

open access: yesBiosafety and Health, 2021
The aim of this study was to evaluate the performance of an assay using dried plasma spot (DPS) and dried blood spot (DBS) samples for the serological detection of anti-hepatitis C virus (HCV) antibodies.
Jieqiong Ma   +6 more
doaj   +1 more source

HCV and Lymphoproliferation [PDF]

open access: yesClinical and Developmental Immunology, 2012
Hepatitis C virus (HCV) infection is a serious public health problem because of its worldwide diffusion and sequelae. It is not only a hepatotropic but also a lymphotropic agent and is responsible not only for liver injury—potentially evolving to cirrhosis and hepatocellular carcinoma—but also for a series of sometimes severely disabling extrahepatic ...
ZIGNEGO, ANNA LINDA   +2 more
openaire   +6 more sources

Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay

open access: yesJournal of Infectious Diseases, 2018
Alison Marshall   +2 more
exaly   +2 more sources

Development and evaluation of serological screening based on one dried plasma spot for HIV, syphilis, and HCV

open access: yesVirology Journal, 2023
Background In the effort to prevent and control HIV/AIDS, China has established a national sentinel surveillance system. However, some sentinel sites face limitations in environmental resources and accessibility, prompting the exploration of alternative ...
Jie-qiong Ma   +5 more
doaj   +1 more source

HCV and the kidney [PDF]

open access: yesLiver International, 2016
AbstractChronic hepatitis C (CHC) is significantly associated with a risk of renal deterioration over time. Renal impairment, especially stage 4–5 chronic kidney disease, increases the risk of: (i) the prevalence and incidence (in dialysis/transplantation) of hepatitis C virus (HCV) infection; (ii) liver deterioration during kidney transplantation and (
Marion, Corouge   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy